Ozempic’s New Frontier: The War on Aging

safety-lane.com 07105
chiropractic-lane.com
www.cbd-lane.com
www.diagnostic-lane.com
NEWARK
http://www.healthy-lane.com

Ozempic’s New Frontier: The War on Aging

Key Points:

GLP-1s, including Ozempic, show promise in preventing age-related conditions like Alzheimer’s, osteoarthritis and certain cancers.

GLP-1s work by suppressing appetite and reducing inflammation, potentially contributing to their preventive health benefits.

While promising, more robust studies are needed to confirm the causal effects of GLP-1s on longevity and healthspan.


Doctors and researchers emphasize the need for larger, more rigorous long-term studies to confirm these preventive effects are causal, not just correlational. 

Still, since Ozempic was approved in 2017, thousands of studies have been published examining the effects of GLP-1s. Last year, Wegovy won a new Food and Drug Administration approval to reduce the risk of heart attacks and other cardiovascular events, and Ozempic, was recently approved to help kidney-disease patients.

This accumulating body of research has led longevity clinics to market and prescribe GLP-1s as so-called gerotherapeutics—drugs that can target certain biological hallmarks of aging

SOURCE

via Blogger https://bit.ly/3FB9lvN